MENU
SPRY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ARS Pharmaceuticals (SPRY) Earnings Date & Reports

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis... Show more

A.I. Advisor
published Earnings

SPRY is expected to report earnings to fall 139.71% to -19 cents per share on May 19

ARS Pharmaceuticals SPRY Stock Earnings Reports
Q1'25
Est.
$-0.19
Q4'24
Beat
by $0.61
Q3'24
Missed
by $0.06
Q2'24
Missed
by $0.01
Q1'24
Missed
by $0.01
The last earnings report on March 20 showed earnings per share of 47 cents, beating the estimate of -12 cents. With 1.19M shares outstanding, the current market capitalization sits at 1.24B.
View a ticker or compare two or three
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11682 El Camino Real
Phone
+1 858 771-9307
Employees
26
Web
https://www.ars-pharma.com